Qin CP - Search Results

1

[Knockdown of CMTM3 promotes migration and invasion of PC3 cell in vitro].

Hu FZ, Yuan WQ, Wang XL, Qin CP, Sheng ZZ, DU YQ, Yin HQ, Xu T. Hu FZ, et al. Among authors: qin cp. Beijing Da Xue Xue Bao Yi Xue Ban. 2016 Aug 18;48(4):594-597. Beijing Da Xue Xue Bao Yi Xue Ban. 2016. PMID: 29263495 Free article. Chinese.

2

CMTM3 is frequently reduced in clear cell renal cell carcinoma and exhibits tumor suppressor activities.

Xie J, Yuan Y, Liu Z, Xiao Y, Zhang X, Qin C, Sheng Z, Xu T, Wang X. Xie J, et al. Clin Transl Oncol. 2014 Apr;16(4):402-9. doi: 10.1007/s12094-013-1092-3. Epub 2013 Aug 2. Clin Transl Oncol. 2014. PMID: 23907292

3

CMTM3 is reduced in prostate cancer and inhibits migration, invasion and growth of LNCaP cells.

Hu F, Yuan W, Wang X, Sheng Z, Yuan Y, Qin C, He C, Xu T. Hu F, et al. Clin Transl Oncol. 2015 Aug;17(8):632-9. doi: 10.1007/s12094-015-1288-9. Epub 2015 May 20. Clin Transl Oncol. 2015. PMID: 25990505

4

[No title available]

[No authors listed] [No authors listed] PMID: 27538133

5

[No title available]

[No authors listed] [No authors listed] PMID: 27538134

6

SOX10 is over-expressed in bladder cancer and contributes to the malignant bladder cancer cell behaviors.

Yin H, Qin C, Zhao Y, Du Y, Sheng Z, Wang Q, Song Q, Chen L, Liu C, Xu T. Yin H, et al. Clin Transl Oncol. 2017 Aug;19(8):1035-1044. doi: 10.1007/s12094-017-1641-2. Epub 2017 Mar 3. Clin Transl Oncol. 2017. PMID: 28258492

7

[Expression of MEK/ERK signal pathways in renal cell carcinoma with bone metastasis].

Qin CP, Liu CL, Zhao YH, Yin HQ, DU YQ, Hu FZ, Sheng ZZ, Xu T. Qin CP, et al. Beijing Da Xue Xue Bao Yi Xue Ban. 2016 Aug 18;48(4):590-593. Beijing Da Xue Xue Bao Yi Xue Ban. 2016. PMID: 29263494 Free article. Chinese.

8

[CacyBP promotes the proliferation and invasion of non-small cell lung cancer].

Xu YJ, Hu YM, Qin C, Wang F, Cao W, Yu YW, Zhao L, Li J, Chen WQ, Li N, He J. Xu YJ, et al. Zhonghua Zhong Liu Za Zhi. 2021 Sep 23;43(9):924-931. doi: 10.3760/cma.j.cn112152-20210421-00329. Zhonghua Zhong Liu Za Zhi. 2021. PMID: 34530574 Chinese.

9

[Establishment of a mutation prediction model for evaluating the efficacy of immunotherapy in renal carcinoma].

Qin CP, Song YX, Ding MT, Wang F, Lin JX, Yang WB, DU YQ, Li Q, Liu SJ, Xu T. Qin CP, et al. Beijing Da Xue Xue Bao Yi Xue Ban. 2022 Aug 18;54(4):663-668. doi: 10.19723/j.issn.1671-167X.2022.04.013. Beijing Da Xue Xue Bao Yi Xue Ban. 2022. PMID: 35950389 Free PMC article. Chinese.

10

[Optimal surveillance intensity of cystoscopy in intermediate-risk non-muscle invasive bladder cancer].

Wang F, Qin CP, DU YQ, Liu SJ, Li Q, Xu T. Wang F, et al. Among authors: qin cp. Beijing Da Xue Xue Bao Yi Xue Ban. 2022 Aug 18;54(4):669-673. doi: 10.19723/j.issn.1671-167X.2022.04.014. Beijing Da Xue Xue Bao Yi Xue Ban. 2022. PMID: 35950390 Free PMC article. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters